Efficacy of apraclonidine 1% versus pilocarpine 4% for prophylaxis of intraocular pressure spike after argon laser trabeculoplasty

Ophthalmology

Volumn 106, Issue 6, 1999, Pages 1135-1139

  Ren, Jianming ^a   Shin, Dong H ^a   Chung, Hak S ^a   Birt, Catherine M ^b   Glover, Bernice K ^a   Juzych, Mark S ^a   Hughes, Bret A ^a   Kim, Chaesik ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APRACLONIDINE; PILOCARPINE;

ADULT; AGED; ARGON LASER; ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG CHOICE; DRUG EFFICACY; FEMALE; HUMAN; INTRAOCULAR HYPERTENSION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MIOSIS; OPEN ANGLE GLAUCOMA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; TRABECULOPLASTY; VISUAL IMPAIRMENT;

EID: 0033504345     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(99)90260-9     Document Type: Article

References (26)

1. Krupin T, Kolker AE, Kass MA, Becker B. Intraocular pressure the day of argon laser trabeculoplasty in primary open-angle glaucoma. Ophthalmology 1984;91:361-5.
2. The Glaucoma Laser Trial. I. Acute effects of argon laser trabeculoplasty on intraocular pressure. Glaucoma Laser Trial Research Group. Arch Ophthalmol 1989;107:1135-42.
3. Weinreb RN, Ruderman J, Juster R, Zweig K. Immediate intraocular pressure response to argon laser trabeculoplasty. Am J Ophthalmol 1983;95:279-86.
4. Hoskins HD Jr, Hetherington J Jr, Minckler DS, et al. Complications of laser trabeculoplasty. Ophthalmology 1983;90: 796-9.
5. Dapling RB, Cunliffe IA, Longstaff S. Influence of apraclonidine and pilocarpine alone and in combination on post laser trabeculoplasty pressure rise. Br J Ophthalmol 1994;78: 30-2.
6. Ofner S, Samples JR, van Buskirk EM. Pilocarpine and the increase in intraocular pressure after trabeculoplasty [letter]. Am J Ophthalmol 1984;97:647-9.
7. Threlkeld AB, Assalian AA, Allingham RR, Shields MB. Apraclonidine 0.5% versus 1% for controlling intraocular pressure elevation after argon laser trabeculoplasty. Ophthalmic Surg Lasers 1996;27:657-60.
8. The Brimonidine-ALT Study Group. Effect of brimonidine 0.5% on intraocular pressure spikes following 360° argon laser trabeculoplasty. Ophthalmic Surg Lasers 1995;26: 404-9.
9. Cullom RD Jr, Schwartz LW. The effect of apraclonidine on the intraocular pressure of glaucoma patients following Nd: YAG laser posterior capsulotomy. Ophthalmic Surg 1993;24: 623-6.
10. David R, Spaeth GL, Clevenger CE, et al. Brimonidine in the prevention of intraocular pressure elevation following argon laser trabeculoplasty. Arch Ophthalmol 1993;111:1387-90.
11. Shin DH, Frenkel RE, David R, Cheetham JK. Effect of topical anti-inflammatory treatment on the outcome of laser trabeculoplasty. The Fluorometholone-Laser Trabeculoplasty Study Group. Am J Ophthalmol 1996;122:349-54.
12. Rosenberg LF, Krupin T, Ruderman J, et al. Apraclonidine and anterior segment laser surgery. Comparison of 0.5% versus 1.0% apraclonidine for prevention of postoperative intraocular pressure rise. Ophthalmology 1995;102:1312-8.
13. Leung KW, Gillies WE. The detection and management of the acute rise in intraocular pressure following laser trabeculoplasty. Aust N Z J Ophthalmol 1986;14:259-62.
14. Brown RH, Stewart RH, Lynch MG, et al. ALO 2145 reduces the intraocular pressure elevation after anterior segment laser surgery. Ophthalmology 1988;95:378-84.
15. Pollack IP, Brown RH, Crandall AS, et al. Prevention of the rise in intraocular pressure following neodymium-YAG posterior capsulotomy using topical 1% apraclonidine. Arch Ophthalmol 1988;106:754-7.
16. Robin AL. The role of apraclonidine hydrochloride in laser therapy for glaucoma. Trans Am Ophthalmol Soc 1989;87: 729-61.
17. Robin AL, Pollack IP, deFaller JM. Effects of topical ALO 2145 (p-aminoclonidine hydrochloride) on the acute intraocular pressure rise after argon laser iridotomy. Arch Ophthalmol 1987;105:1208-11.
18. Robin AL, Pollack IP, House B, Enger C. Effects of ALO 2145 on intraocular pressure following argon laser trabeculoplasty. Arch Ophthalmol 1987;105:646-50.
19. Robin AL. Effect of topical apraclonidine on the frequency of intraocular pressure elevations after combined extracapsular cataract extraction and trabeculectomy. Ophthalmology 1993; 100:628-33.
20. Pollack IP, Robin AL, Sax H. The effect of argon laser trabeculoplasty on the medical control of primary open-angle glaucoma. Ophthalmology 1983;90:785-9.
21. Schwartz AL, Love DC, Schwartz MA. Long-term follow-up of argon laser trabeculoplasty for uncontrolled open-angle glaucoma. Arch Ophthalmol 1985;103:1482-4.
22. Schrems W, Eichelbronner O, Krieglstein GK. The immediate IOP response of Nd-YAG-laser iridotomy and its prophylactic treatability. Acta Ophthalmol (Copenh) 1984;62:673-80.
23. Brown SVL, Thomas JV, Belcher CD III, Simmons RJ. Effect of pilocarpine in treatment of intraocular pressure elevation following neodymium:YAG laser posterior capsulotomy. Ophthalmology 1985;92:354-9.
24. Richter CU, Arzeno G, Pappas HR, et al. Prevention of intraocular pressure elevation following neodymium-YAG laser posterior capsulotomy. Arch Ophthalmol 1985;103: 912-5.
25. Chung HS, Shin DH, Birt CM, et al. Chronic use of apraclonidine decreases its moderation of post-laser intraocular pressure spikes. Ophthalmology 1997;104:1921-5.
26. Robin AL. Argon laser trabeculoplasty medical therapy to prevent the intraocular pressure rise associated with argon laser trabeculoplasty. Ophthalmic Surg 1991;22:31-7.